These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 22333366)
21. Assessing walking disability in multiple sclerosis. Kieseier BC; Pozzilli C Mult Scler; 2012 Jul; 18(7):914-24. PubMed ID: 22740603 [TBL] [Abstract][Full Text] [Related]
22. The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory. Engelhard MM; Schmidt KM; Engel CE; Brenton JN; Patek SD; Goldman MD Qual Life Res; 2016 Dec; 25(12):3221-3230. PubMed ID: 27342237 [TBL] [Abstract][Full Text] [Related]
23. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D. Hawton A; Green C; Telford CJ; Wright DE; Zajicek JP Mult Scler; 2012 Jun; 18(6):853-61. PubMed ID: 22108867 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theory. Mokkink LB; Galindo-Garre F; Uitdehaag BM Mult Scler; 2016 Dec; 22(14):1867-1873. PubMed ID: 26873891 [TBL] [Abstract][Full Text] [Related]
25. Validity, invariance and responsiveness of a self-report measure of functional limitations and disability in multiple sclerosis. Motl RW; McAuley E; Suh Y Disabil Rehabil; 2010; 32(15):1260-71. PubMed ID: 20131947 [TBL] [Abstract][Full Text] [Related]
26. Validity of the 30-Second Sit-to-Stand test as a measure of lower extremity function in persons with multiple sclerosis: Preliminary evidence. Zheng P; Huynh TLT; Jones CD; Feasel CD; Jeng B; Motl RW Mult Scler Relat Disord; 2023 Mar; 71():104552. PubMed ID: 36774829 [TBL] [Abstract][Full Text] [Related]
27. Estimating a minimal clinically important difference for the EuroQol 5-Dimension health status index in persons with multiple sclerosis. Kohn CG; Sidovar MF; Kaur K; Zhu Y; Coleman CI Health Qual Life Outcomes; 2014 May; 12():66. PubMed ID: 24886430 [TBL] [Abstract][Full Text] [Related]
28. The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis. Learmonth YC; Dlugonski DD; Pilutti LA; Sandroff BM; Motl RW Mult Scler; 2013 Nov; 19(13):1784-91. PubMed ID: 23587605 [TBL] [Abstract][Full Text] [Related]
29. Self-efficacy and walking performance across the lifespan among adults with multiple sclerosis. Sikes EM; Cederberg KL; Baird JF; Sandroff BM; Motl RW Neurodegener Dis Manag; 2019 Oct; 9(5):267-275. PubMed ID: 31580224 [No Abstract] [Full Text] [Related]
30. Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study. Kalron A; Ehling R; Baert I; Smedal T; Rasova K; Heric-Mansrud A; Elorriage I; Nedeljkovic U; Tachino A; Gargul L; Gusowski K; Cattaneo D; Borgers S; Hebert J; Dalgas U; Feys P Mult Scler Relat Disord; 2020 Nov; 46():102511. PubMed ID: 32949848 [TBL] [Abstract][Full Text] [Related]
31. Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures. Freeman J; Walters R; Ingram W; Slade A; Hobart J; Zajicek J Mult Scler; 2013 Oct; 19(12):1632-9. PubMed ID: 23530002 [TBL] [Abstract][Full Text] [Related]
32. Examining the validity of the multiple-sclerosis walking scale-12 with Rasch analysis: Results from an Italian study. Marengo D; Rosato R; Gamberini G; Cavalla P; Gironi M; Patti F; Prosperini L; Solaro C Mult Scler Relat Disord; 2019 Nov; 36():101400. PubMed ID: 31557678 [TBL] [Abstract][Full Text] [Related]
33. Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12). McGuigan C; Hutchinson M Neurology; 2004 Jun; 62(11):2103-5. PubMed ID: 15184625 [TBL] [Abstract][Full Text] [Related]
34. The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community. Wicks P; Vaughan TE; Massagli MP Health Qual Life Outcomes; 2012 Jun; 10():70. PubMed ID: 22709981 [TBL] [Abstract][Full Text] [Related]
35. Validity of the dynamic gait index in people with multiple sclerosis. Forsberg A; Andreasson M; Nilsagård YE Phys Ther; 2013 Oct; 93(10):1369-76. PubMed ID: 23641026 [TBL] [Abstract][Full Text] [Related]
36. Do patient and proxy agree? Long-term changes in multiple sclerosis physical impact and walking ability on patient-reported outcome scales. Sonder JM; Balk LJ; Bosma LV; Polman CH; Uitdehaag BM Mult Scler; 2014 Oct; 20(12):1616-23. PubMed ID: 24710798 [TBL] [Abstract][Full Text] [Related]
37. Predicting accidental falls in people with multiple sclerosis -- a longitudinal study. Nilsagård Y; Lundholm C; Denison E; Gunnarsson LG Clin Rehabil; 2009 Mar; 23(3):259-69. PubMed ID: 19218300 [TBL] [Abstract][Full Text] [Related]
38. Step-rate thresholds for physical activity intensity in persons with multiple sclerosis. Agiovlasitis S; Motl RW Adapt Phys Activ Q; 2014 Jan; 31(1):4-18. PubMed ID: 24385438 [TBL] [Abstract][Full Text] [Related]
39. Walking capacities in multiple sclerosis measured by global positioning system odometer. Créange A; Serre I; Levasseur M; Audry D; Nineb A; Boërio D; Moreau T; Maison P; Mult Scler; 2007 Mar; 13(2):220-3. PubMed ID: 17439888 [TBL] [Abstract][Full Text] [Related]
40. Caregiver burden, quality of life and walking ability in different disability levels of multiple sclerosis. Ertekin Ö; Özakbaş S; İdiman E NeuroRehabilitation; 2014; 34(2):313-21. PubMed ID: 24419020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]